The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $7.09

Today's change-0.07 -0.98%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $7.09

Today's change-0.07 -0.98%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.

Spectrum Pharmaceuticals Inc crosses below 20-day moving average

Spectrum Pharmaceuticals Inc closed lower Friday, dropping (U.S.)$0.07 or 0.98% to (U.S.)$7.09 and crossing below its 20-day moving average. Shares have lost 6.71% over the last five days, but have gained 17.58% over the last year to date. This security has outperformed the S&P 500 by 23.58% during the last year.

Key company metrics

  • Open(U.S.) $7.14
  • Previous close(U.S.) $7.16
  • High(U.S.) $7.25
  • Low(U.S.) $7.03
  • Bid / Ask(U.S.) $6.83 / (U.S.) $7.83
  • YTD % change+17.58%
  • Volume416,570
  • Average volume (10-day)547,522
  • Average volume (1-month)761,923
  • Average volume (3-month)867,708
  • 52-week range(U.S.) $4.14 to (U.S.) $7.74
  • Beta1.39
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.78
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.47%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue50294539
Total other revenue--------
Total revenue50294539
Gross profit44203932
Total cost of revenue6867
Total operating expense53454560
Selling / general / administrative21192323
Research & development15101016
Depreciation / amortization107714
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-3-160-22
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-19-2-25
Income after tax-4-19-2-26
Income tax, total0000
Net income-4-19-2-26
Total adjustments to net income--------
Net income before extra. items-4-19-2-26
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-19-2-26
Inc. avail. to common incl. extra. items-4-19-2-26
Diluted net income-4-19-2-26
Dilution adjustment--------
Diluted weighted average shares63666565
Diluted EPS excluding extraordinary itemsvalue per share-0.07-0.28-0.04-0.39
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.07-0.28-0.04-0.39